isphagula husk

Botanicalexperimental

Clinical trial activity

4 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2002 (NCT02165475)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ispaghula husk
  • isphagula husk

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06689813N/AFeb 1, 2024Shalamar Institute of Health Sciences
NCT02888899N/AMar 1, 2016Linkoping University
NCT00748787Phase 2Oct 1, 2008Badalona Hospital Germans Trias i Pujol, Rottapharm, Rovira i Virgili University, University of Las Palmas de Gran Canaria, University of Valladolid
NCT02165475N/AMay 1, 2002Linkoping University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Linkoping UniversityAcademic/Hospital2212002
Badalona Hospital Germans Trias i PujolAcademic/Hospital1012008
RottapharmFor profit1112008
Rovira i Virgili UniversityAcademic/Hospital1012008
Shalamar Institute of Health SciencesAcademic/Hospital1112024
University of Las Palmas de Gran CanariaAcademic/Hospital1012008
University of ValladolidAcademic/Hospital1012008
7 organizations
Page 1 / 1